亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Melatonin for migraine prevention in children and adolescents: A randomized, double‐blind, placebo‐controlled trial after single‐blind placebo lead‐in

偏头痛 安慰剂 单盲板 双盲 褪黑素 随机对照试验 医学 安慰剂对照研究 偏头痛 心理学 精神科 麻醉 内科学 替代医学 病理
作者
Amy A. Gelfand,Isabel Elaine Allen,Barbara Grimes,Samantha Irwin,William Qubty,Kaitlin Greene,Maggie W. Waung,Scott W. Powers,Christina L. Szperka
出处
期刊:Headache [Wiley]
卷期号:63 (9): 1314-1326 被引量:9
标识
DOI:10.1111/head.14600
摘要

BACKGROUND: Melatonin is effective for migraine prevention in adults. We hypothesized that melatonin would also be effective for migraine prevention in children and adolescents. METHODS: This was a randomized, double-blind trial of melatonin (3 mg or 6 mg) versus placebo for migraine prevention in 10-17 year-olds with 4-28/28 headache days at baseline. Participants were recruited from the UCSF Child & Adolescent Headache Program, UCSF child neurology clinic, and social media advertisements. Migraine diagnosis was confirmed by a headache specialist. Participants completed an 8-week single-blind placebo run-in. Those meeting randomization criteria (≥4 headache days and ≥23/28 electronic diary entries during weeks 5-8) were randomized 1:1:1 to placebo:melatonin 3 mg:melatonin 6 mg nightly for 8 weeks. The primary outcome measure was migraine days in weeks 5-8 of randomized treatment between melatonin (combined 6 mg + 3 mg) versus placebo. We aimed to enroll n = 210. RESULTS: The study closed early due to slow enrollment (n = 72). Two participants were in the single-blind phase when the study closed, therefore the meaningful n = 70. Sixteen percent (11/70) were lost to follow-up during the single-blind phase. An additional 21% (15/70) did not meet randomization criteria (<4 headache days: n = 5, <23/28 diary days: n = 7, both: n = 3). Sixty-three percent (44/70) were eligible to randomize, of whom 42 randomized (n = 14 per arm). Taking another preventive at enrollment (OR 8.3, 95% CI 1.01 to 68.9) was the only variable associated with meeting randomization criteria. Of those randomized, 91% (38/42) provided diary data in the final 4-weeks. However, given the amount of missing data, only those with ≥21/28 diary days were analyzed-7/14 (50%) in the placebo group, and 20/28 (71%) in the melatonin groups combined. Median (IQR) migraine/migrainous days in weeks 5-8 of double-blind treatment was 2 (1-7) in the placebo group versus 2 (1-12) in the melatonin groups combined; the difference in medians (95% CI for the difference) was 0 days (-9 to 3). There were no differences in adverse events between groups. CONCLUSIONS: When compared to recall at enrollment, headache days decreased across the single-blind placebo phase and the double-blind phase. There was no suggestion of superiority of melatonin; however, given the substantial portion of missing data, numerically higher in the placebo arm, and underpowering, this should not be interpreted as proof of inefficacy. Melatonin was generally well tolerated with no serious adverse events. Future migraine preventive trials in this age group may find this trial helpful for anticipating enrollment needs if using a single-blind placebo run-in. Enriching for those already on a migraine preventive may improve randomization rates in future trials, though would change the generalizability of results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
北极小熊完成签到,获得积分10
2秒前
3秒前
369ninja的应助被雪山大地采纳,获得10
6秒前
7秒前
8秒前
9秒前
12秒前
王佳佳发布了新的文献求助10
16秒前
华无剑的应助被雪山大地采纳,获得10
21秒前
栀鸢发布了新的文献求助30
24秒前
28秒前
28秒前
31秒前
高高的仇血完成签到,获得积分10
31秒前
cc发布了新的文献求助10
32秒前
casualplay发布了新的文献求助10
33秒前
木齐Jay完成签到,获得积分10
39秒前
华仔的应助被雪山大地采纳,获得10
40秒前
所所的应助被十四采纳,获得10
42秒前
隐形曼青的应助被lyw采纳,获得10
44秒前
aa完成签到,获得积分10
44秒前
obedVL完成签到,获得积分10
45秒前
xiaoping发布了新的文献求助10
51秒前
暮飘飘完成签到,获得积分20
54秒前
科研通AI6.4的应助被谨慎夏烟采纳,获得10
55秒前
55秒前
菌菌完成签到,获得积分10
56秒前
jj完成签到,获得积分10
1分钟前
1分钟前
醉熏的孤云完成签到,获得积分10
1分钟前
lyw发布了新的文献求助10
1分钟前
daomaihu完成签到,获得积分10
1分钟前
XNG完成签到,获得积分10
1分钟前
casualplay完成签到,获得积分10
1分钟前
GingerF的应助被Cherie77采纳,获得50
1分钟前
快乐的雁露完成签到,获得积分10
1分钟前
1分钟前
丘比特的应助被甜甜的悲采纳,获得10
1分钟前
嘻嘻哈哈的应助被科研通管家采纳,获得10
1分钟前
小蘑菇的应助被科研通管家采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165968
求助须知:如何正确求助?哪些是违规求助? 9559406
关于积分的说明 21750034
捐赠科研通 7756757
什么是DOI,文献DOI怎么找? 3429092
关于科研通互助平台的介绍 2553386
邀请新用户注册赠送积分活动 2473672